Ping An Healthcare and Technology Company Limited (Stock Code: 1833) reported unaudited revenue of RMB3,724.6 million for the nine months ended 30 September 2025, marking a 13.6% increase compared to the same period in 2024. Its net profit rose by 72.6% year on year to RMB183.8 million, and adjusted net profit, excluding share-based payments and foreign exchange losses, increased by 45.7% to RMB216.1 million.

According to the announcement, revenue from both F-end and B-end corporate health management segments grew by 21.5%, driven in part by enhanced product capabilities and deeper collaboration with Ping An Insurance (Group) Company of China, Ltd. The number of enterprises served exceeded 4,500, and the number of B-end paying users increased by 30.6% year on year.

During the reporting period, overall family doctor membership exceeded 40 million, supported by a dual-certified medical team and integration of AI technology to improve professional services. The home-based senior care segment also recorded a 41% increase in users compared to the end of 2024, focusing on medical service, health management, emergency rescue, and remote care.

The announcement highlighted further expansion of AI integration to improve medical service efficiency and quality, with multidisciplinary treatment accuracy improving to nearly 90% and average service costs per customer decreasing by about 52% year on year.

The data is based on the preliminary internal review and has not been audited. Shareholders and potential investors are advised to exercise caution when dealing in the shares of Ping An Healthcare (1833).